Hepato Cellular Carcinoma (HCC)

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular Carcinoma

Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC

Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab

Hepatocellular Carcinoma Identification Using Delta-HLD

Effect and Mechanism of ALPPS Operation on Liver Regeneration

PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma

Retrospective Clinical Validation of HepatoPredict

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Ex-vivo Hypotermic Perfusion in Patients with Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC